Eliquis

Pfizer

Pharma

Pfizer's COVID franchise keeps guidance level after strong Q1

Buoyed by notable sales beats from Eliquis, Prevnar and Ibrance, Pfizer’s revenue rose 2% year over year on an operational basis to $14.5 billion.

Fraiser Kansteiner May 5, 2026 11:17am

BMS

BMS maintains Camzyos confidence amid Cytokinetics competition

Apr 30, 2026 2:20pm

BMS

BMS turns focus to new growth drivers as legacy meds decline

Feb 5, 2026 11:45am

woman sitting on couch using smartphone

BMS, Pfizer to provide discounted Eliquis through online program

Jul 17, 2025 10:59am

Bristol Myers Squibb

After $1.5B cost-cutting plan, BMS will cut an additional $2B

Feb 6, 2025 8:33am

pink slip

BMS cuts 195 jobs, bringing head count reduction to 1,329 in NJ

Nov 25, 2024 12:59pm